Crimson staff writer
Richard Y. Zhu
This is the Boston Lung Cancer Study, a long-running study of lung cancer patients that analyzes the disease’s genetic and environmental risk factors. But in recent years, the study reached a new frontier in medicine. The Harvard Artificial Intelligence in Medicine program has begun analyzing the dataset in unprecedented ways — by using artificial intelligence.